Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC)

被引:111
|
作者
Zhao, Y. -F. [1 ]
Ma, X. -Q. [1 ]
Wang, R. [1 ]
Yan, X. -Y. [2 ]
Li, Z. -S. [3 ]
Zou, D. -W. [3 ]
He, J. [1 ]
机构
[1] Second Mil Med Univ, Dept Hlth Stat, Shanghai 200433, Peoples R China
[2] Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China
[3] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; BODY-MASS INDEX; QUALITY-OF-LIFE; PREVALENCE; SYMPTOMS; VALIDATION; DISORDERS; COMMUNITY; HABITS; GENDER;
D O I
10.1111/j.1365-2036.2011.04809.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The epidemiology and effects of functional constipation (FC) on Chinese people remain unclear. Aim To investigate the epidemiology of FC and its distinction from constipation-predominant irritable bowel syndrome (IBS-C) in China. Methods A cross-sectional survey was conducted in a representative adult Chinese population (n = 16 078), which was selected from five regions using randomised, stratified, multistage sampling methodology. All respondents completed the modified Rome II questionnaire; 20% were asked to complete the 36-item Short Form (SF-36) and the Epworth Sleepiness Scale (ESS). Results Overall, 948 respondents (6%) had FC and FC was more prevalent in women than in men (8% vs. 4%, P < 0.001). Straining and hard stools were the two most frequent symptoms. FC was associated significantly with dyspepsia and abdominal bloating. All SF-36 domain scores were lower for respondents with FC than for those without. The prevalence of clinically meaningful daytime sleepiness was significantly higher in respondents with FC than in those without (22% vs. 14%, P = 0.003). Respondents with FC were more likely to strain, but less likely to have a feeling of incomplete emptying after a bowel movement than those with IBS-C. Respondents with IBS-C experienced similar demographics, quality of life and daytime sleepiness to those with FC. Conclusions The prevalence of FC in China is substantially lower than that in Western countries. FC has negative effects on quality of life and daytime sleepiness. The demographics and burden of illness are similar between FC and IBS-C, although the clinical symptoms are somewhat different. Aliment Pharmacol Ther 2011; 34: 1020-1029
引用
下载
收藏
页码:1020 / 1029
页数:10
相关论文
共 50 条
  • [21] Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China
    Lv, Chao-Lan
    Song, Geng-Qing
    Liu, Jie
    Wang, Wei
    Huang, Yi-Zhou
    Wang, Bo
    Tian, Jia-Shuang
    Yin, Meng-Qing
    Yu, Yue
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (41) : 5657 - 5667
  • [22] Functional Constipation and Constipation-Predominant Irritable Bowel Syndrome in the General Population: Data from the GECCO Study
    Enck, Paul
    Leinert, Johannes
    Smid, Menno
    Koehler, Thorsten
    Schwille-Kiuntke, Juliane
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [23] Effect of Renzapride on Transit in Constipation-Predominant Irritable Bowel Syndrome
    Camilleri, Michael
    McKinzie, Sanna
    Fox, Jean
    Foxx-Orenstein, Amy
    Burton, Duane
    Thomforde, George
    Baxter, Kari
    Zinsmeister, Alan R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (10) : 895 - 904
  • [24] Polyethylene Glycol in Constipation-Predominant Irritable Bowel Syndrome Response
    Chapman, R. W.
    Stanghellini, V.
    Geraint, M.
    Halphen, M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (01): : 136 - 136
  • [25] Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome
    Maria I. Vazquez-Roque
    Ernest P. Bouras
    Advances in Therapy, 2013, 30 : 203 - 211
  • [26] Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome
    Vazquez-Roque, Maria I.
    Bouras, Ernest P.
    ADVANCES IN THERAPY, 2013, 30 (03) : 203 - 211
  • [27] Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide
    Yu, Siegfried W. B.
    Rao, Satish S. C.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2014, 7 (05): : 193 - 205
  • [28] Constipation and Constipation-predominant Irritable Bowel Syndrome: A Comparative Study Using Rome III Criteria
    Rajindrajith, Shaman
    Devanarayana, Niranga M.
    Benninga, Marc A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 64 (05): : 679 - 684
  • [29] Cisapride treatment of constipation-predominant irritable bowel syndrome is not superior to placebo
    Ziegenhagen, DJ
    Kruis, W
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (07) : 744 - 749
  • [30] Potential effects of sodium hyaluronate on constipation-predominant irritable bowel syndrome
    Cui, Li
    Zou, Shuting
    Liu, Jing
    Lv, Huixia
    Li, Hui
    Zhang, Zhenhai
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 127